{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:55:43Z","timestamp":1771620943940,"version":"3.50.1"},"reference-count":53,"publisher":"American Veterinary Medical Association (AVMA)","issue":"6","license":[{"start":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T00:00:00Z","timestamp":1651968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2022,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>To evaluate IV iron sucrose safety and impact on hematologic and iron indices in healthy cats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>ANIMALS<\/jats:title>\n<jats:p>5 healthy research cats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>PROCEDURES<\/jats:title>\n<jats:p>Cats were administered iron sucrose (0.5 mg\/kg, IV) over 30 minutes. Monitoring for acute reactions (temperature, heart rate, respiratory rate, and blood pressure) was performed every 5 minutes during injection and every 15 minutes for an additional hour. Baseline, 24-hour, and 1-, 2-, and 3-week postinjection measurements of CBC with reticulocyte indices, iron panel (ferritin, total iron-binding capacity, and iron), calculated transferrin saturation (TSAT), and serum amyloid A (SAA) concentration were performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>No cat experienced an acute drug reaction. SAA concentration was increased at 24 hours versus baseline. TSAT and ferritin decreased over time, with 3 cats developing concurrent functional iron deficiency (FID) and anemia. Hct (Spearman correlation [<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>] = 0.805), hemoglobin (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub> = 0.770), and reticulocyte hemoglobin content (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub> = 0.581) correlated with TSAT.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CLINICAL RELEVANCE<\/jats:title>\n<jats:p>IV iron sucrose was well tolerated in healthy cats but was associated with transient increase in the systemic inflammatory marker SAA. Efficacy evaluation of dose based on iron deficit is needed in sick cats. Despite cumulative blood draw volume below recommended limits, anemia and FID were observed, which has important implications for experimental designs and serial hematologic monitoring. Further evaluation of inflammatory response to IV iron sucrose administration is warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/ajvr.21.11.0186","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T19:16:56Z","timestamp":1651864616000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous iron sucrose is safe but does not prevent development of anemia or iron deficiency in healthy cats undergoing serial venipuncture"],"prefix":"10.2460","volume":"83","author":[{"given":"Rebecca","family":"Ullom-Minnich","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"McKisson","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Kastl","sequence":"additional","affiliation":[{"name":"Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Jugan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"B1","series-title":"Iron Metabolism: from Molecular Mechanisms to Clinical Consequences","year":"2009","unstructured":"Crichton RR. Iron Metabolism: from Molecular Mechanisms to Clinical Consequences. 3rd ed. John Wiley & Sons, Ltd; 2009. doi: 10.1002\/9780470010303."},{"issue":"Suppl 1","key":"B2","series-title":"J Lab Hematol","first-page":"S20","article-title":"The mutual control of iron and erythropoiesis","volume":"38","year":"2016","unstructured":"Camaschella C, Pagani A, Nai A, Silvestri L. The mutual control of iron and erythropoiesis. J Lab Hematol. 2016;38(Suppl 1):S20\u201326. doi: 10.1111\/ijlh.12505."},{"key":"B3","series-title":"Clinical Biochemistry of Domestic Animals","first-page":"259","article-title":"Iron metabolism and its disorders","year":"2008","unstructured":"Harvey JW. Iron metabolism and its disorders. In: Bruss ML, Harvey JW, Kaneko JJ, eds. Clinical Biochemistry of Domestic Animals. 6th ed. Academic Press; 2008:259\u2013285. doi: 10.1016\/B978-0-12-370491-7.00009-X."},{"issue":"3","key":"B4","series-title":"Blood Rev","first-page":"95","article-title":"Ferritin for the clinician","volume":"23","year":"2009","unstructured":"Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95\u2013104. doi: 10.1016\/j.blre.2008.08.001.18835072"},{"issue":"5704","key":"B5","series-title":"Science","first-page":"2090","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20132093. doi: 10.1126\/science.1104742.15514116"},{"key":"B6","series-title":"Schalm\u2019s Veterinary Hematology","first-page":"167","article-title":"Iron and copper deficiencies and disorders of iron metabolism","year":"2010","unstructured":"Weiss DJ. Iron and copper deficiencies and disorders of iron metabolism. In: Weiss D, Wardrop KJ, eds. Schalm\u2019s Veterinary Hematology . 6th ed. Wiley-Blackwell; 2010:167\u2013171."},{"issue":"7","key":"B7","series-title":"Transfusion","first-page":"1584","article-title":"Iron deficiency syndromes and iron-restricted erythropoiesis (CME)","volume":"52","year":"2012","unstructured":"Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion. 2012;52(7):1584\u20131592. doi: 10.1111\/j.1537-2995.2011.03495.x.22211566"},{"issue":"4","key":"B8","series-title":"J Comp Pathol","first-page":"304","article-title":"Evaluation of the relationship between selected reticulocyte parameters and inflammation determined by plasma C-reactive protein in dogs","volume":"152","year":"2015","unstructured":"Mel\u00e9ndez-Lazo A, Tvarijonaviciute A, Cer\u00f3n JJ, Planellas M, Pastor J. Evaluation of the relationship between selected reticulocyte parameters and inflammation determined by plasma C-reactive protein in dogs. J Comp Pathol. 2015;152(4):304\u2013312. doi: 10.1016\/j.jcpa.2015.01.008.25804353"},{"issue":"11","key":"B9","series-title":"Clin Res Cardiol","first-page":"1352","article-title":"Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study","volume":"109","year":"2020","unstructured":"Schrage B, Rubsamen N, Schulz A, Munzel T, Pfeiffer N, Wild PS. Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study. Clin Res Cardiol. 2020;109(11):1352\u20131357. doi: 10.1007\/s00392-020-01631-y.32215702"},{"key":"B10","series-title":"Adv Exp Med Biol","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-4615-2554-7_24","article-title":"Iron deficiency: the global perspective","volume":"356","year":"1994","unstructured":"Cook JD, Skikne BS, Baynes RD. Iron deficiency: the global perspective. Adv Exp Med Biol. 1994;356:219\u2013228. doi: 10.1007\/978-1-4615-2554-7_24.7887226"},{"issue":"2","key":"B11","series-title":"J Health Popul Nutr","first-page":"175","article-title":"Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy","volume":"20","year":"2002","unstructured":"Hyder SM, Persson LA, Chowdhury AM, Ekstr\u00f6m EC. Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr. 2002;20(2):175\u2013179.12186198"},{"issue":"1","key":"B12","series-title":"Am J Clin Nutr","first-page":"145","article-title":"Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial","volume":"78","year":"2003","unstructured":"Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr. 2003;78(1):145\u2013153. doi: 10.1093\/ajcn\/78.1.145.12816784"},{"issue":"4","key":"B13","series-title":"Am J Hematol","first-page":"261","article-title":"Intravenous iron in a primary-care clinic","volume":"78","year":"2005","unstructured":"Maslovsky I. Intravenous iron in a primary-care clinic. Am J Hematol. 2005;78(4):261\u2013264. doi: 10.1002\/ajh.20271."},{"issue":"10","key":"B14","series-title":"Gut","first-page":"1309","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","year":"2011","unstructured":"Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309\u20131316. doi: 10.1136\/gut.2010.228874.21561874"},{"issue":"1","key":"B15","series-title":"Cochrane Database Syst Rev","first-page":"CD013529","article-title":"Interventions for treating iron deficiency anaemia in inflammatory bowel disease","volume":"1","year":"2021","unstructured":"Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, et al. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database Syst Rev. 2021;1(1):CD013529. doi: 10.1002\/14651858.CD013529.pub2.33471939"},{"issue":"12","key":"B16","series-title":"Med Oncol","first-page":"302","article-title":"Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy","volume":"31","year":"2014","unstructured":"Hedenus M, Karlsson T, Ludwig H, et al. Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Med Oncol. 2014;31(12):302. doi: 10.1007\/s12032-014-0302-3.25373320"},{"issue":"2","key":"B17","series-title":"J Crohn\u2019s Colitis","first-page":"97","article-title":"Intravenous iron therapy restores functional iron deficiency induced by infliximab","volume":"1","year":"2007","unstructured":"Katsanos K, Cavalier E, Ferrante M, et al. Intravenous iron therapy restores functional iron deficiency induced by infliximab. J Crohn\u2019s Colitis. 2007;1(2):97\u2013105. doi: 10.1016\/j.crohns.2007.08.005."},{"issue":"1","key":"B18","series-title":"Br J Pharmacol Chemother","first-page":"107","article-title":"Local effects and mechanism of absorption of iron preparations administered intramuscularly","volume":"12","year":"1957","unstructured":"Beresford CR, Golberg L, Smith JP. Local effects and mechanism of absorption of iron preparations administered intramuscularly. Br J Pharmacol Chemother. 1957;12(1):107\u2013114. doi: 10.1111\/j.1476-5381.1957.tb01371.x.13413161"},{"issue":"9","key":"B19","series-title":"J Pak Med Assoc","first-page":"392","article-title":"Comparative study\u2013efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy","volume":"52","year":"2002","unstructured":"Wali A, Mushtaq A, Nilofer. Comparative study\u2013efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. J Pak Med Assoc. 2002;52(9):392\u2013395.12532571"},{"key":"B20","series-title":"Kidney Int","first-page":"S64","article-title":"Controversies in iron management","volume":"87","year":"2003","unstructured":"Nissenson AR, Charytan C. Controversies in iron management. Kidney Int. 2003; 87:S64\u201371. doi: 10.1046\/j.1523-1755.64.s87.10.x."},{"issue":"1","key":"B21","series-title":"Am J Hematol","first-page":"74","article-title":"Parenteral iron therapy options","volume":"76","year":"2004","unstructured":"Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol. 2004;76(1):74\u201378. doi: 10.1002\/ajh.20056.15114602"},{"issue":"3","key":"B22","series-title":"Blood Transfus","first-page":"296","article-title":"Safety of intravenous iron formulations: facts and folklore","volume":"12","year":"2014","unstructured":"Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014;12(3):296\u2013300. doi: 10.2450\/2014.0094-14.25074787"},{"issue":"4","key":"B23","series-title":"Am J Kidney Dis","first-page":"588","article-title":"Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial","volume":"61","year":"2013","unstructured":"Goldstein SL, Morris D, Warady BA. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Am J Kidney Dis. 2013;61(4):588\u2013597. doi: 10.1053\/j.ajkd.2012.10.019."},{"issue":"6","key":"B24","series-title":"J Vet Intern Med","first-page":"1488","article-title":"Iron status of cats with chronic kidney disease","volume":"29","year":"2015","unstructured":"Gest J, Langston C, Eatroff A. Iron status of cats with chronic kidney disease. J Vet Intern Med. 2015;29(6):1488\u20131493. doi: 10.1111\/jvim.13630.26417695"},{"issue":"1","key":"B25","series-title":"J Vet Intern Med","first-page":"172","article-title":"Anemia, iron deficiency, and cobalamin deficiency in cats with chronic gastrointestinal disease","volume":"35","year":"2021","unstructured":"Hunt A, Jugan MC. Anemia, iron deficiency, and cobalamin deficiency in cats with chronic gastrointestinal disease. J Vet Intern Med. 2021;35(1):172\u2013178. doi: 10.1111\/jvim.15962.33226151"},{"issue":"6","key":"B26","series-title":"J Small Anim Pract","first-page":"323","article-title":"Investigation of iron status and markers of inflammation in anaemic and non-anaemic hospitalised cats","volume":"58","year":"2017","unstructured":"von Roedern M, Buriko Y, Prittie J, Lamb K. Investigation of iron status and markers of inflammation in anaemic and non-anaemic hospitalised cats. J Small Anim Pract. 2017;58(6):323\u2013329. doi: 10.1111\/jsap.12658."},{"issue":"5","key":"B27","series-title":"Anesth Analg","first-page":"1763","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","year":"2018","unstructured":"Schober BC, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20131768. doi: 10.1213\/ANE.0000000000002864.29481436"},{"issue":"6","key":"B28","series-title":"J Crohn\u2019s Colitis","first-page":"429","article-title":"State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease","volume":"7","year":"2013","unstructured":"Reinisch W, Staun M, Bhandari S, Mu\u00f1oz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohn\u2019s Colitis. 2013;7(6):429\u2013440. doi: 10.1016\/j.crohns.2012.07.031."},{"issue":"2","key":"B29","series-title":"Vet Clin Path","first-page":"172","article-title":"Reticulocyte indices in a canine model of nutritional iron deficiency","volume":"35","year":"2006","unstructured":"Fry MM, Kirk CA. Reticulocyte indices in a canine model of nutritional iron deficiency. Vet Clin Path. 2006;35(2):172\u2013181."},{"issue":"4","key":"B30","series-title":"Vet Clin Path","first-page":"511","article-title":"Reticulocyte hemoglobin content does not differentiate true from functional iron deficiency in dogs","volume":"44","year":"2015","unstructured":"Radakovich LB, Santagelo KS, Oliver CS. Reticulocyte hemoglobin content does not differentiate true from functional iron deficiency in dogs. Vet Clin Path. 2015;44(4):511\u2013518. doi: 10.1111\/vcp.12294."},{"issue":"1","key":"B31","series-title":"Vet Clin Path","first-page":"109","article-title":"The utility of reticulocyte indices in distinguishing iron deficiency anemia from anemia of inflammatory disease, portosystemic shunting, and breed-associated microcytosis in dogs","volume":"44","year":"2015","unstructured":"Schaefer DM, Stokol T. The utility of reticulocyte indices in distinguishing iron deficiency anemia from anemia of inflammatory disease, portosystemic shunting, and breed-associated microcytosis in dogs. Vet Clin Path. 2015;44(1):109\u2013119. doi: 10.1111\/vcp.12219."},{"issue":"7","key":"B32","series-title":"Nephrol Dial Transplant","first-page":"1438","article-title":"Benchmarking iron dextran sensitivity: reactions requiring resuscitative mediation in incident prevalent patients","volume":"20","year":"2005","unstructured":"Walters BA, Wyck DB. Benchmarking iron dextran sensitivity: reactions requiring resuscitative mediation in incident prevalent patients. Nephrol Dial Transplant. 2005;20(7):1438\u20131442. doi: 10.1093\/ndt\/gfh811."},{"issue":"1","key":"B33","series-title":"Mayo Clinic Proc","first-page":"12","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","year":"2015","unstructured":"Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clinic Proc. 2015;90(1):12\u201323. doi: 10.1016\/j.mayocp.2014.10.007."},{"issue":"1","key":"B34","series-title":"Am J Kidney Dis","first-page":"88","article-title":"Safety and efficacy of iron sucrose in patients sensitive to iron dextran","volume":"36","year":"2000","unstructured":"Van Wyck DB, Cavallo G, Spinowitz BS, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran. Am J Kidney Dis. 2000;36(1):88\u201397. doi: 10.1053\/ajkd.2000.8276.10873877"},{"key":"B35","series-title":"Free Radic Biol Med","first-page":"1174","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","year":"2013","unstructured":"Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013;65:1174\u20131194. doi: 10.1016\/j.freeradbiomed.2013.09.001.24036104"},{"key":"B36","series-title":"BMC Hematol","first-page":"1","article-title":"Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: a feasibility study","volume":"16","year":"2016","unstructured":"Louzada ML, Hsia CC, Al-Ani F, Ralley F, Xenocostas A, Martin J. Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: a feasibility study. BMC Hematol. 2016;16:1\u20138."},{"issue":"4","key":"B37","series-title":"J Vet Med Sci","first-page":"545","article-title":"Evaluation of serum amyloid A (SAA) as an inflammatory marker","volume":"65","year":"2003","unstructured":"Sasaki K, Ma Z, Khatlani TS, Okuda M, Inokuma H, Onishi T. Evaluation of serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci. 2003;65(4):545\u2013548. doi: 10.1292\/jvms.65.545.12736442"},{"issue":"4","key":"B38","series-title":"Biometals","first-page":"603","article-title":"Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose","volume":"24","year":"2011","unstructured":"Pai AB, Conner T, McQuade CR, Olp J, Hicks P. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. Biometals. 2011;24(4):603\u2013613. doi: 10.1007\/s10534-011-9409-6."},{"issue":"6","key":"B39","series-title":"Kidney Int","first-page":"2279","article-title":"Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease","volume":"65","year":"2004","unstructured":"Argawal R, Vasavada N, Sachs NG, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int. 2004;65(6):2279\u20132289. doi: 10.1111\/j.1523-1755.2004.00648.x.15149341"},{"issue":"6","key":"B40","series-title":"Am J Nephrol","first-page":"572","article-title":"Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran","volume":"27","year":"2007","unstructured":"Malindretos P, Sarafidis PA, Rudenco I, et al. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. Am J Nephrol. 2007;27(6):572\u2013579. doi: 10.1159\/000107928."},{"issue":"2","key":"B41","series-title":"Int Urol Nephrol","first-page":"387","article-title":"Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients","volume":"52","year":"2020","unstructured":"Mitsopoulos E, Lysitska A, Pateinakis P, et al. Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients. Int Urol Nephrol. 2020;52(2):387\u2013392. doi: 10.1007\/s11255-019-02362-4.31894555"},{"issue":"3","key":"B42","series-title":"Nephron Clin Pract","first-page":"249","article-title":"Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran","volume":"118","year":"2011","unstructured":"Steffanson BV, Haraldsson B, Nilsson U. Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran. Nephron Clin Pract. 2011;118(3):249\u2013256. doi: 10.1159\/000321645."},{"issue":"6","key":"B43","series-title":"Arzneimittelforschung","first-page":"615","article-title":"Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers","volume":"46","year":"1996","unstructured":"Danielson BG, Salmonson T, Derendorf H, Geisser P. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung. 1996;46(6):615\u2013621.8767353"},{"issue":"1","key":"B44","series-title":"Pharmaceutics","first-page":"12","article-title":"The pharmacokinetics and pharmacodynamics of iron preparations","volume":"3","year":"2011","unstructured":"Geisser P, Burckhardt S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011;3(1):12\u201333. doi: 10.3390\/pharmaceutics3010012.24310424"},{"issue":"2","key":"B45","series-title":"Ann Fam Med","first-page":"133","article-title":"Elevated serum transferrin saturation and mortality","volume":"2","year":"2004","unstructured":"Mainous AG, Gill JM, Carek PJ. Elevated serum transferrin saturation and mortality. Ann Fam Med. 2004;2(2):133\u2013138. doi: 10.1370\/afm.25.15083853"},{"issue":"2","key":"B46","series-title":"Br J Haematol","first-page":"296","article-title":"Pharmacokinetics and red cell utilization of iron(III)-hydroxidesucrose complex in anaemic patients: a study using positron emission tomography","volume":"104","year":"1999","unstructured":"Beshara S, Lundqvist H, Sundin J, et al. Pharmacokinetics and red cell utilization of iron(III)-hydroxidesucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol, 1999;104(2):296\u2013302. doi: 10.1046\/j.1365-2141.1999.01179.x.10050711"},{"issue":"2","key":"B47","series-title":"Adv Chronic Kidney Dis","first-page":"143","article-title":"Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?","volume":"16","year":"2009","unstructured":"Kalantar K, Streja E, Miller JE, Nissenson AR. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis. 2009;16(2):143\u2013151. doi: 10.1053\/j.ackd.2008.12.008.19233073"},{"issue":"3","key":"B48","series-title":"Am J Hematol","first-page":"223","article-title":"Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis","volume":"65","year":"2000","unstructured":"Barton JC, Bottomley SS. Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis. Am J Hematol. 2000;65(3):223\u2013226.11074539"},{"issue":"1","key":"B49","series-title":"Vet Immunol Immunopathol","first-page":"91","article-title":"Changes in concentrations of serum amyloid A protein, \u03b11-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery","volume":"68","year":"1999","unstructured":"Kajikawa T, Furuta A, Onishi T, Tajima T, Sugii S. Changes in concentrations of serum amyloid A protein, \u03b11-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Vet Immunol Immunopathol. 1999;68(1):91\u201398. doi: 10.1016\/S0165-2427(99)00012-4."},{"issue":"3","key":"B50","series-title":"J Vet Emerg Crit Care","first-page":"406","article-title":"Development of anemia, phlebotomy practices, and blood transfusion requirements in 45 critically ill cats (2009-2011)","volume":"26","year":"2016","unstructured":"Balakrishanan A, Drobatz KJ, Reineke EL. Development of anemia, phlebotomy practices, and blood transfusion requirements in 45 critically ill cats (2009-2011). J Vet Emerg Crit Care. 2016;26(3):406\u2013411. doi: 10.1111\/vec.12363."},{"issue":"21","key":"B51","series-title":"Br J Pharmacol","first-page":"5025","article-title":"Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management","volume":"172","year":"2015","unstructured":"Szebeni J, Fishbane S, Hedenus M, et al. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol. 2015;172(21):5025\u20135036. doi: 10.1111\/bph.13268.26265306"},{"issue":"7","key":"B52","series-title":"Schweizerische Medizinische Wochenschrift","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities","volume":"100","year":"1970","unstructured":"Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweizerische Medizinische Wochenschrift. 1970;100(7):301\u2013303.5413918"},{"issue":"Suppl 2","key":"B53","series-title":"J Am Soc Nephrol","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","year":"2004","unstructured":"Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol. 2004;15(Suppl 2):S93\u201398. doi: 10.1097\/01.ASN.0000143814.49713.C5.15585603"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/6\/ajvr.21.11.0186.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/6\/ajvr.21.11.0186.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/6\/ajvr.21.11.0186.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:11:11Z","timestamp":1748614271000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/6\/ajvr.21.11.0186.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,8]]},"references-count":53,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.21.11.0186","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,8]]}}}